~~<i id='B0883D5C91'><strike id='B0883D5C91'><tt id='B0883D5C91'><pre id='B0883D5C91'></pre></tt></strike></i>~~

Home» focus» leisure time

leisure time

author：knowledge 2025-10-02 04:17:04 Page View：41

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Listen: Racing for gene therapy & a pioneering approval
Next article： Moonlake's readout produced a cash windfall. Risks remain

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

Cancer drug shortages' outsize impact on ovarian cancer patients

SarahEvans,ofSyracuse,N.Y.,hasbeenaffectedbyovariancancerdrugshortages.MichelleGabelforSTATSarahEvan

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Living with Hashimoto's and celiac disease, and med school, too

BriannaCelix:Havingtwoautoimmunediseasesis"my‘why’formedicine."Photoillustration:CaseySheneryforSTAT

WSS

leisure time

leisure time

explore

knowledge

Living with Hashimoto's and celiac disease, and med school, too